These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Pattern recognition by pentraxins. Agrawal A; Singh PP; Bottazzi B; Garlanda C; Mantovani A Adv Exp Med Biol; 2009; 653():98-116. PubMed ID: 19799114 [TBL] [Abstract][Full Text] [Related]
3. Pentraxins: multifunctional proteins at the interface of innate immunity and inflammation. Deban L; Bottazzi B; Garlanda C; de la Torre YM; Mantovani A Biofactors; 2009; 35(2):138-45. PubMed ID: 19449441 [TBL] [Abstract][Full Text] [Related]
8. Pentraxins in innate immunity: from C-reactive protein to the long pentraxin PTX3. Mantovani A; Garlanda C; Doni A; Bottazzi B J Clin Immunol; 2008 Jan; 28(1):1-13. PubMed ID: 17828584 [TBL] [Abstract][Full Text] [Related]
9. PTX3 as a paradigm for the interaction of pentraxins with the complement system. Inforzato A; Doni A; Barajon I; Leone R; Garlanda C; Bottazzi B; Mantovani A Semin Immunol; 2013 Feb; 25(1):79-85. PubMed ID: 23747040 [TBL] [Abstract][Full Text] [Related]
10. Long pentraxin 3 (PTX3) in the light of its structure, mechanism of action and clinical implications. Cieślik P; Hrycek A Autoimmunity; 2012 Mar; 45(2):119-28. PubMed ID: 21988562 [TBL] [Abstract][Full Text] [Related]
11. The long pentraxin PTX3 as a key component of humoral innate immunity and a candidate diagnostic for inflammatory diseases. Jaillon S; Bonavita E; Gentile S; Rubino M; Laface I; Garlanda C; Mantovani A Int Arch Allergy Immunol; 2014; 165(3):165-78. PubMed ID: 25531094 [TBL] [Abstract][Full Text] [Related]
12. Pentraxins and Fc receptors. Lu J; Marjon KD; Mold C; Du Clos TW; Sun PD Immunol Rev; 2012 Nov; 250(1):230-8. PubMed ID: 23046133 [TBL] [Abstract][Full Text] [Related]
13. Pentraxins in humoral innate immunity. Inforzato A; Bottazzi B; Garlanda C; Valentino S; Mantovani A Adv Exp Med Biol; 2012; 946():1-20. PubMed ID: 21948359 [TBL] [Abstract][Full Text] [Related]
14. The long pentraxin PTX3 at the crossroads between innate immunity and tissue remodelling. Inforzato A; Jaillon S; Moalli F; Barbati E; Bonavita E; Bottazzi B; Mantovani A; Garlanda C Tissue Antigens; 2011 Apr; 77(4):271-82. PubMed ID: 21388349 [TBL] [Abstract][Full Text] [Related]
15. The yin-yang of long pentraxin PTX3 in inflammation and immunity. Daigo K; Mantovani A; Bottazzi B Immunol Lett; 2014 Sep; 161(1):38-43. PubMed ID: 24792672 [TBL] [Abstract][Full Text] [Related]
16. The Long Pentraxin PTX3 as a Link Between Innate Immunity, Tissue Remodeling, and Cancer. Doni A; Stravalaci M; Inforzato A; Magrini E; Mantovani A; Garlanda C; Bottazzi B Front Immunol; 2019; 10():712. PubMed ID: 31019517 [TBL] [Abstract][Full Text] [Related]
17. Biology of human pentraxin 3 (PTX3) in acute and chronic kidney disease. Speeckaert MM; Speeckaert R; Carrero JJ; Vanholder R; Delanghe JR J Clin Immunol; 2013 Jul; 33(5):881-90. PubMed ID: 23443958 [TBL] [Abstract][Full Text] [Related]
18. The long pentraxin PTX3: a paradigm for humoral pattern recognition molecules. Mantovani A; Valentino S; Gentile S; Inforzato A; Bottazzi B; Garlanda C Ann N Y Acad Sci; 2013 May; 1285():1-14. PubMed ID: 23527487 [TBL] [Abstract][Full Text] [Related]
19. Pentraxins (CRP, SAP) in the process of complement activation and clearance of apoptotic bodies through Fcγ receptors. Du Clos TW; Mold C Curr Opin Organ Transplant; 2011 Feb; 16(1):15-20. PubMed ID: 21150611 [TBL] [Abstract][Full Text] [Related]
20. Pentraxins in Complement Activation and Regulation. Ma YJ; Garred P Front Immunol; 2018; 9():3046. PubMed ID: 30619374 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]